Acute Behavioral Effects of Triazolam and Caffeine, Alone and in Combination, in Humans

被引:14
作者
Rush, Craig R. [1 ,2 ]
Higgins, Stephen T. [1 ,2 ]
Hughes, John R. [1 ,2 ]
Bickel, Warren K. [1 ,2 ]
机构
[1] Univ Vermont, Dept Psychiat, 38 Fletcher Pl, Burlington, VT 05401 USA
[2] Univ Vermont, Dept Psychol, Burlington, VT 05405 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1037/1064-1297.2.3.211
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
The acute behavioral effects of triazolam (0, 0.375, and 0.75 mg/70 kg) and caffeine (0, 250, and 500 mg/70 kg), alone and in combination, were assessed in 9 male volunteers. Ss received all possible dose combinations according to a Latin square design. Triazolam administered alone dose dependently disrupted learning and performance on the Repeated Acquisition and Performance procedure and the Digit Symbol Substitution Test and increased S ratings of sedation. Caffeine administered alone did not significantly affect learning or performance measures, but it did dose dependently increase S ratings of drug strength. Caffeine significantly attenuated triazolam-induced decrements in learning and performance. Consistent with effects on learning and performance, caffeine offset triazolam-induced increases in S ratings of sedation. Combining caffeine and triazolam did not significantly alter increases in S ratings of drug strength observed with caffeine alone. These effects are qualitatively similar to those observed with other benzodiazepines (e.g., lorazepam) and document a high degree of consistency in the behavioral pharmacology of benzodiazepine-caffeine combinations in humans.
引用
收藏
页码:211 / 222
页数:12
相关论文
共 33 条
[1]   THE EFFECTS OF DIAZEPAM AND TRIAZOLAM ON REPEATED ACQUISITION AND PERFORMANCE OF RESPONSE SEQUENCES WITH AN OBSERVING RESPONSE [J].
BICKEL, WK ;
HIGGINS, ST ;
HUGHES, JR .
JOURNAL OF THE EXPERIMENTAL ANALYSIS OF BEHAVIOR, 1991, 56 (02) :217-237
[2]   CAFFEINE [J].
DEWS, PB .
ANNUAL REVIEW OF NUTRITION, 1982, 2 :323-341
[3]  
DUNBAR GC, 1988, BRIT J ADDICT, V83, P689
[4]  
EVANS SM, 1991, BEHAV PHARMACOL, V2, P345
[5]  
FILE SE, 1982, J CLIN PSYCHOPHARM, V2, P102
[6]  
GHONEIM MM, 1986, J CLIN PSYCHOPHARM, V6, P75
[7]  
Gilbert R M, 1984, Prog Clin Biol Res, V158, P185
[8]  
Gilbert R. M., 1976, RES ADV ALCOHOL DRUG, P49
[9]   CAFFEINISM ASSOCIATED WITH GREATER USE OF OTHER PSYCHOTROPIC AGENTS [J].
GREDEN, JF ;
PROCTER, A ;
VICTOR, B .
COMPREHENSIVE PSYCHIATRY, 1981, 22 (06) :565-571
[10]  
Haertzen C. A., 1974, DHEW PUB, VADM-79